- Home
- ONC vs CTSH Comparison
ONC vs CTSH Comparison
Compare ONC & CTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | CTSH |
|---|---|---|
| Founded | 2010 | 1994 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 29.4B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ONC | CTSH |
|---|---|---|
| Price | $309.60 | $57.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | ★ $374.75 | $85.00 |
| AVG Volume (30 Days) | 187.3K | ★ 4.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ 1.11 |
| EPS | N/A | ★ 4.56 |
| Revenue | N/A | ★ $21,108,000,000.00 |
| Revenue This Year | $747.23 | $8.18 |
| Revenue Next Year | $15.78 | $5.04 |
| P/E Ratio | $614.06 | ★ $12.99 |
| Revenue Growth | N/A | ★ 6.95 |
| 52 Week Low | $227.40 | $58.08 |
| 52 Week High | $385.22 | $87.03 |
Technical Indicators
Market Signals| Indicator | ONC | CTSH |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 32.27 |
| Support Level | $307.93 | N/A |
| Resistance Level | $320.35 | $63.06 |
| Average True Range (ATR) | 7.68 | 1.81 |
| MACD | 4.77 | 0.14 |
| Stochastic Oscillator | 82.89 | 8.35 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About CTSH Cognizant Technology Solutions Corporation
Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.